CIK: 1274139 - Address: C/O Recursion Pharmaceuticals, 41 S. Rio Grande Street, Salt Lake City, UT 84101
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
10/7/26 18:08
10/6/26
RXRXRecursion Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagHershberg RobertUTDM.d562.2202518162D
10/7/26 18:08
10/6/26
RXRXRecursion Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagHershberg RobertUTDS.d-1255.000-25-13162D
8/20/26 17:55
8/18/26
ADPTAdaptive Biotechnologies CorpWAHealthBioPrdBiological Products, (No DiagHershberg RobertWADM.d956.320154747D
8/20/26 17:55
8/18/26
ADPTAdaptive Biotechnologies CorpWAHealthBioPrdBiological Products, (No DiagHershberg RobertWADS.d-74824.400-31-4047D
7/9/26 17:30
7/7/26
ATAIAtaibeckley Inc.DEHealthDrugPharmaceutical PreparationsHershberg RobertNYDM.d1351.350100New100D
7/9/26 17:30
7/7/26
ATAIAtaibeckley Inc.DEHealthDrugPharmaceutical PreparationsHershberg RobertNYDS.d-4964.960-100-50100D
12/12/25 19:11
12/10/25
ADPTAdaptive Biotechnologies CorpWAHealthBioPrdBiological Products, (No DiagHershberg RobertWADS-36716.000-23-3347D
3/12/25 19:48
3/12/25
ADPTAdaptive Biotechnologies CorpWAHealthBioPrdBiological Products, (No DiagHershberg RobertWADS-4027.590-53-4370D
2/12/25 16:05
2/4/25
HLVXHillevax, Inc.DEHealthBioPrdBiological Products, (No DiagHershberg RobertMADOSee RemaS.m-491.830-27-21,101D
2/12/24 19:47
2/8/24
HLVXHillevax, Inc.DEHealthBioPrdBiological Products, (No DiagHershberg RobertMADOSee RemaS.d-17314.930-12-11,128D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact